Century Pharmaceuticals


Century Pharmaceuticals, Inc. is a third-generation, family-owned company specializing in manufacturing safe, effective, and affordable wound care solutions. With a history dating back to 1916 and a legacy of over a century of helping patients heal, the company produces a range of sodium hypochlorite-based wound cleansers and solutions that are used worldwide by healthcare professionals, hospitals, and pharmacies. Their products are designed to support wound healing at every stage, combat antimicrobial resistance, and provide reliable, long-lasting wound management options. The company emphasizes the importance of careful wound cleansing to prevent moisture-associated skin damage (MASD) and non-healing wounds, offering solutions that reduce bacteria, disrupt biofilms, and promote healing. They advocate for the use of Dakin’s Solution as a safe, non-cytotoxic, and effective wound cleanser that can be integrated into various wound care protocols, including negative pressure wound therapy (NPWT) and wound irrigation. The company also addresses the critical issue of antibiotic resistance, promoting their wound cleansers as alternatives to antibiotics that help reduce bioburden and biofilm formation without contributing to antimicrobial resistance. Their products support advanced wound care techniques, such as NPWT with antimicrobial instillation, and are suitable for managing complex and chronic wounds, including those affected by moisture-associated skin damage (MASD) and non-healing wounds. Dakin’s Solution is available in multiple concentrations and formats, making it accessible and cost-effective for healthcare providers and patients alike. The company is committed to improving wound healing outcomes, reducing infection risks, and supporting antimicrobial stewardship through their innovative wound care products.

Industries

chemical
manufacturing
pharmaceutical

Nr. of Employees

small (1-50)

Century Pharmaceuticals

Indianapolis, Indiana, United States, North America


Products

Buffered sodium hypochlorite wound cleanser — 0.0125% (low concentration)

Low-concentration, pH‑balanced topical wound cleanser for irrigation, gauze soaks, and wound dressings; formulated to minimize cytotoxicity with extended shelf life.

Buffered sodium hypochlorite wound cleanser — intermediate concentrations

Mid- and higher-strength, pH‑buffered topical wound cleansers for irrigation and dressing use, intended for higher bioburden wounds with guidance on application and skin protection.

Topical irrigation and spray delivery systems

Sprayer and irrigation bottle formats for controlled topical application to wounds enabling targeted cleansing and mechanical removal of debris.

Surface disinfectant formulation (environmental cleanser)

Sodium hypochlorite-based surface cleanser intended for rapid environmental disinfection across multiple materials with extended shelf-life claims.


Services

Complimentary healthcare sample program

Provision and shipment of complimentary product samples to healthcare facilities for evaluation (limit one per customer).

Wholesale onboarding and distributor support

Support for wholesalers and distributors to add pre-formulated wound-cleansing products to catalogs, including specification documentation and ordering guidance.

Direct bulk orders and case fulfillment

Sale and shipping of product cases with typical ship times for bulk institutional orders.

Clinical usage guidance for MASD, non-healing wounds, and NPWT integration

Published clinical guidance and procedural approaches for use of topical antimicrobial rinses in MASD care, non-healing wounds, and integration with NPWT instillation and dressing soak techniques.

Antimicrobial stewardship resources

Educational materials describing the role of non-antibiotic topical rinses in reducing bioburden, disrupting biofilm, and supporting reduced reliance on systemic antibiotics in wound care.

Expertise Areas

  • Wound care formulation and topical antimicrobial development
  • Clinical wound irrigation and dressing protocols
  • Moisture-associated skin damage (MASD) management
  • Biofilm disruption and bioburden reduction
  • Show More (6)

Key Technologies

  • Buffered sodium hypochlorite topical formulations
  • pH buffering for topical stability
  • Stability testing and lot-based shelf-life monitoring
  • Rapid contact-kill antimicrobial assays
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.